New eye treatment aims to halt worsening vision
NCT ID NCT04094090
Summary
This study is testing a new medical device called the PXL-Platinum 330 system. It uses a special light treatment called corneal cross-linking to try to stop progressive thinning and bulging of the cornea in conditions like keratoconus. Researchers will enroll 500 patients aged 10 and older to see if this treatment is safe and effective at stabilizing the eye's shape and preserving vision over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Goodman Eye Center
RECRUITINGSan Francisco, California, 94115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.